Evidence map›Paper›PMID 33432238›Full record

ArticleNature chemical biology2021

A cytochrome c is the natural electron acceptor for nicotine oxidoreductase.

Mark Dulchavsky, Christopher T Clark, James C A Bardwell, Frederick Stull

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Rational Design of a Flavoenzyme for Aerobic Nicotine Catabolism.bioRxiv : the preprint server for biology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Novel Monooxygenase GeneApplied and environmental microbiology · 2022
    Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mark DulchavskyHoward Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-5253-8924
Christopher T ClarkDepartment of Chemistry, Western Michigan University, Kalamazoo, MI, USA.
James C A BardwellHoward Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA. jbardwel@umich.edu.
Frederick StullDepartment of Chemistry, Western Michigan University, Kalamazoo, MI, USA. frederick.stull@wmich.edu.ORCID http://orcid.org/0000-0002-2969-4224
Howard Hughes Medical Institute · USWestern Michigan University · US

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
Howard Hughes Medical InstituteNIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

Nicotine oxidoreductase (NicA2), a member of the flavin-containing amine oxidase family, is of medical relevance as it shows potential as a therapeutic to aid cessation of smoking due to its ability to oxidize nicotine into a non-psychoactive metabolite. However, the use of NicA2 in this capacity is stymied by its dismal O

Indexed as

AlkaloidsAnimalsBacterial ProteinsBinding SitesBiotransformationCattleCloning, MolecularCytochromes cEscherichia coliFlavin-Adenine DinucleotideGene ExpressionGenetic VectorsKineticsModels, MolecularNicotineOxidation-ReductionAlkaloidsBacterial ProteinsCytochromes cFlavin-Adenine DinucleotidemyosmineNicotineOxidoreductasesRecombinant Proteins

Identifiers

PMID33432238
PMCPMC7904663
OpenAlexW3118868681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.